Haemoglobin D disease (Q39526): Difference between revisions

← Older edit

@@ Property / Canonical URI @@
+https://id.who.int/icd/entity/1508363690
@@ Property / Canonical URI: https://id.who.int/icd/entity/1508363690 / rank @@
+Normal rank
@@ Property / CURIE @@
+CID11:3A51.6
@@ Property / CURIE: CID11:3A51.6 / rank @@
+Normal rank
@@ Property / Canary Token @@
+dki-india-3A51.6
@@ Property / Canary Token: dki-india-3A51.6 / rank @@
+Normal rank
@@ Property / Verification Status @@
+Concluído
@@ Property / Verification Status: Concluído / rank @@
+Normal rank
@@ Property / Knowledge Architect @@
+https://pauloleads.com.br/cases-publicos/
+Normal rank
@@ Property / Collection date @@
+August 2026Timestamp +2026-08-13T00:00:00Z
Timezone +00:00
Calendar Gregorian
Precision 1 day
Before 0
After 0
-Timestamp
++2026-08-13T00:00:00Z
-Timezone
++00:00
-Calendar
+Gregorian
-Precision
+day
 Before
 After
@@ Property / Collection date: 13 August 2026 / rank @@
+Normal rank
@@ Property / Linked ICD 10 @@
+D57
@@ Property / Linked ICD 10: D57 / rank @@
+Normal rank

Latest revision as of 04:58, 13 August 2026

Haemoglobin D (Hb D) disease is characterised by mild haemolytic anaemia and mild to moderate splenomegaly. Prevalence is unknown. Heterozygous forms of Hb D are clinically silent. Molecular testing can be useful to distinguish Hb D homozygosity from cases of heterozygous Hb D in association with beta-(0) thalassaemia.

Language	Label	Description	Also known as
default for all languages	3A51.6
English	Haemoglobin D disease	Haemoglobin D (Hb D) disease is characterised by mild haemolytic anaemia and mild to moderate splenomegaly. Prevalence is unknown. Heterozygous forms of Hb D are clinically silent. Molecular testing can be useful to distinguish Hb D homozygosity from cases of heterozygous Hb D in association with beta-(0) thalassaemia.